| 107.91 Delayed Data As of 6:30pm ET |  -0.73 / -0.67%Today’s Change | 104.17 Today|||52-Week Range 132.13 | -6.75% Year-to-Date |
| 3 Dividend-Paying Pharma Stocks to Buy Now Oct 15 / MotleyFool.com - Paid Partner Content | Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding? Oct 11 / MotleyFool.com - Paid Partner Content |
| Previous close | 108.64 |
| Today’s open | 108.87 |
| Day’s range | 107.77 - 109.00 |
| Volume | 4,079,997 |
| Average volume (3 months) | 3,529,348 |
| Market cap | $104.9B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +3.04% |
| Earnings growth (next 5 years) | +9.60% |
| Revenue growth (last year) | +7.36% |
| P/E ratio | 25.6 |
| Price/Sales | 4.87 |
| Price/Book | 11.69 |
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | +0.07 | +0.16% |
| ABBVAbbVie | +0.84 | +1.10% |
| NVONovo Nordisk | +0.08 | +0.15% |
| AZNAstraZeneca | -0.15 | -0.34% |
| Next reporting date | October 23, 2019 |
| EPS forecast (this quarter) | $1.39 |
| Annual revenue (last year) | $24.6B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 13.16% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
